Pharmexa's Chief Commercial Officer resigns

27-Aug-2007

Chief Commercial Officer (CCO) Peter Nordkild has resigned his position in Pharmexa to accept the position as CEO in the Danish biotech company Egalet. Peter Nordkild's responsibilities will until further notice be taken over by Chief Executive Officer Jakob Schmidt.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance